Related Experiment Video
Updated: Jun 26, 2026

Noninvasive Sampling of Mucosal Lining Fluid for the Quantification of In Vivo Upper Airway Immune-mediator Levels
Published on: August 7, 2017
First evidence of a possible association between gastric acid suppression during pregnancy and childhood asthma: a
E Dehlink1, E Yen, A M Leichtner
1Division of Gastroenterology and Nutrition, Children's Hospital Boston, Harvard Medical School, Boston, MA 02115, USA.
Insights
Maternal use of acid-suppressive medications during pregnancy was linked to an increased risk of childhood asthma in offspring. This study provides evidence of a significant association between in utero drug exposure and asthma development.
Area of Science:
- Pediatric Allergy and Immunology
- Perinatal Pharmacology
- Epidemiology
Background:
- Emerging data in mice suggest prenatal acid suppression may predispose offspring to allergies.
- Understanding the impact of maternal medication use on child health is crucial.
Purpose of the Study:
- To investigate the association between in utero exposure to acid-suppressive drugs and the development of allergic diseases in children.
- To determine if prenatal exposure to acid suppression increases the risk of childhood asthma.
Main Methods:
- A population-based cohort study utilizing Swedish national healthcare registers.
- Linking data on maternal medication use, birth outcomes, and childhood diagnoses/prescriptions for allergic diseases.
- Statistical analysis using the Mantel-Haenszel procedure to assess associations.
Main Results:
- Prenatal exposure to acid-suppressive medications was associated with an increased risk of childhood allergy (OR 1.43).
- This association persisted regardless of drug type, timing, or maternal allergy history.
- A significant increase in the odds of developing childhood asthma was observed (OR 1.51), but not other allergic diseases.
Conclusions:
- This study presents the first evidence linking in utero exposure to acid-suppressive drugs with an elevated risk of childhood asthma.
- Further research is warranted to elucidate the mechanisms behind this association and its clinical implications.
Background:
Recent data in mice suggest that acid suppression during pregnancy yields offspring with type 2 T helper-dominant immunity, suggesting a predisposition for allergy.
Objective:
To determine the association of in utero exposure to acid-suppressive medications and the subsequent development of allergic diseases in children.
Methods:
We studied a population-based observational cohort formed by linking data from three Swedish national healthcare registers: the Medical Birth Register, the Hospital Discharge Register, and the Swedish Prescribed Drug Register. Main outcome measures included a hospital discharge diagnosis of an allergic disease or prescription for asthma medications, epinephrine auto-injectors, antihistamines or steroid ointments in children. Data were analysed using the Mantel-Haenszel procedure.
Results:
Twenty-nine thousand four hundred and ninety (5.03%) children had a discharge diagnosis of allergy or prescriptions for allergy medications. Five thousand six hundred and forty-five (0.96%) children had been exposed to acid suppression therapy during pregnancy; of these, 405 (0.07%) were treated for allergic diseases. Exposure to acid-suppressive medications in utero was associated with an increased odds ratio (OR) for developing allergy (OR 1.43, 95% confidence interval (95% CI) 1.29-1.59). We observed this association irrespective of the type of drug, time of exposure during pregnancy, and maternal history of allergy. The use of maternal acid-suppressive medication was associated with an increased OR for the development of childhood asthma (3.7% in the population at large vs. 5.6% in exposed children, OR 1.51, 95% CI 1.35-1.69), but not for other allergic diseases.
Conclusion:
These data provide first evidence of a significant association between in utero exposure to acid-suppressive drugs and the risk of developing childhood asthma.
Related Concept Videos
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by anesthetizing...
Asthma-I: Introduction
Asthma I: Introduction
Asthma III: Clinical Manifestations
Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists
Gastroesophageal Reflux Disease II: Clinical Features and Management
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
